Login / Signup

Endoscopic surveillance alone is feasible and safe in type I gastric neuroendocrine neoplasms less than 10 mm in diameter.

Klaire ExarchouHaiyi HuNathan A StephensAndrew R MooreMark KellyAngela LamarcaWasat MansoorRichard HubnerMairéad G McNamaraHoward SmartNathan R HowesJuan W ValleDavid Mark Pritchard
Published in: Endocrine (2022)
Patients with ≤10 mm type I g-NENs were unlikely to develop clinically significant tumour progression and in most cases, resection was not needed. The endoscopic surveillance interval could therefore potentially be safely increased to every 2-3 years in such patients. However, lifelong surveillance is still advocated due to the additional risk of developing gastric adenocarcinoma.
Keyphrases
  • public health
  • end stage renal disease
  • ultrasound guided
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • squamous cell carcinoma
  • peritoneal dialysis
  • prognostic factors
  • optical coherence tomography